Negative regulation of proopiomelanocortin gene expression by GABAA receptor activation in the rat arcuate nucleus.
Activation of the GABAA-benzodiazepine receptor complex has previously been shown to inhibit the release proopiomelanocortin (POMC)-related peptides from the hypothalamus and to decrease mRNA levels in POMC neurons in the arcuate nucleus. To learn more about the precise role of the GABAergic system in POMC neuron regulation, we studied the effects of the administration (2 days) of the GABAA receptor agonist muscimol and the central-type barbiturate receptor agonist pentobarbital on POMC mRNA levels measured by in situ hybridization. Treatment with pentobarbital produced a 12% decrease in the hybridization signal. Similarly, muscimol treatment decreased the signal by 20%. The concomitant administration of the two GABAA receptor agonists resulted in a decrease (28%) of mRNA levels that was significantly more marked than that induced by pentobarbital or muscimol alone. The present results, together with previous data from our laboratory, indicate that different activators of the GABAA receptor complex, including barbiturates, can negatively regulate POMC neuronal activity in the rat arcuate nucleus.
Garcia de Yebenes
E
E
MRC Group in Molecular Endocrinology, CHUL Research Center, Québec, Canada.
Pelletier
G
G
D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000187:drug effects*; D058785:GABA-A Receptor Agonists; D005786:Gene Expression Regulation / Q000187:drug effects*; D017403:In Situ Hybridization; D008297:Male; D009118:Muscimol / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology*; D011333:Pro-Opiomelanocortin / Q000235:genetics*; D051381:Rats; D017207:Rats, Sprague-Dawley
D058785:GABA-A Receptor Agonists; D009118:Muscimol; D011333:Pro-Opiomelanocortin; D010424:Pentobarbital